Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11

Similar documents
Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

Workshop B Control Strategy

Quality Risk Management Tools Quality Risk Management Tool Selection When to Select FMEA: QRM Tool Selection Matrix

Quality Risk Management ICH Q9 & ISO Presented by Michael Kerr 11 th November 2011

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Quality Risk Management Principles and Industry Case Studies

Best Practice In A Change Management System

Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach

Quality Risk Management

QUALITY RISK MANAGEMENT (QRM): A REVIEW

Risk Assessment and Management. Allen L. Burgenson Manager, Regulatory Affairs Lonza Walkersville Inc.

Workshop A Design Space (DS)

FMEA and FTA Analysis

TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS

Quality Risk Management Understanding and Control the Risk in Pharmaceutical Manufacturing Industry

Annex 2. WHO guidelines on quality risk management. 1. Introduction Glossary Quality risk management process 70

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

The use of risk assessment tools for microbiological assessment of cleanroom environments. by Tim Sandle

Quality Risk Management in Pharmaceutical Industry: A Review

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4

QUALITY RISK MANAGEMENT

Guidance on Qualification of existing facilities, systems, equipment and utilities

Risk Management for Aseptic Processing

UNICEF s Quality Assurance System for procurement of medicines

Monitoring. Compliant and Reasonable. 5-6 May 2015, Berlin, Germany

Guidance for Industry

Deviation Handling and Quality Risk Management

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

ICH Q9 Quality Risk Management - an industry view. Peter H. Gough, Eli Lilly and Company

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

White Paper. Life Sciences Industry Solution Blueprint for Environmental Monitoring Systems (EMS) ISPE Guidance and Best Practices.

Process Validation: Practical Aspects of the New FDA Guidance

OPER H6001. Pharmaceutical Operations Mgt. APPROVED. Pharmaceutical Operations Management for Engineers. Credits: 5. NFQ Level: 9

Corrective and Preventive Actions

QA GLP audits. Alain Piton. Antipolis,, France.

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

GAMP5 - a lifecycle management framework for customized bioprocess solutions

ICH Q10 - Pharmaceutical Quality System

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online.

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Media fills Periodic performance qualification (Re-Validation)

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations

Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III

Particle testing in cleanroom high-pressure gas lines to ISO made easy with the MET ONE 3400 gas calibrations

Qualification of an Environmental Monitoring Program

Particle Monitoring Requirements in Pharmaceutical Cleanrooms


Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

State of Control Over the Lifecycle and Process Validation (New and Legacy Products)

White paper: FDA Guidance for Industry Update Process Validation

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, Oct 2009

VALIDATION OF CLEAN ROOMS FOR ASEPTIC MANUFACTURING. F.R.Smal Pharmaceutical Director ICCE ICCE a member of SNC-Lavalin Group

Testing Automated Manufacturing Processes

Workshop on process validation

New changes to cleanroom & clean air device classifications: ISO & 2

The Quality System for Drugs in Germany

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle

FDA Guidance for Industry Update - Process Validation

Regulations Concerning

ICH Public Meeting. Joseph C. Famulare. October 2, Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance

WHO GUIDELINE ON QUALITY RISK MANAGEMENT

PHARMACEUTICAL QUALITY SYSTEM Q10

WHO GUIDELINE ON QUALITY RISK MANAGEMENT

Risk assessment is used as a

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

Raleigh, NC May 12 th & 13 th Meeting The New ISO Cleanroom Standards And Changing EU Guidance How Will You Comply?

World Health Organization WHO Technical Report Series, No. 961, 2011

The Technical Compliance Manager

Hazard Analysis and Critical Control Points (HACCP) 1 Overview

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Quality by Design (QbD) Overview

IMPURITIES IN NEW DRUG PRODUCTS

Guidance for Industry

ICH guideline Q10 on pharmaceutical quality system

Engineering for the new pharma reality

Standard Operating Procedure Title: Quality Risk Management Techniques

Implementing New USP Chapters for Analytical Method Validation

FAILURE INVESTIGATION AND ROOT CAUSE ANALYSIS

SUPPLEMENTARY GUIDELINES ON

Managing Clinical Trial Risk: It's a Tough Job, But One Person Has To Do It

What to control? CQAs and CPPs

Guideline on Process Validation

STOPPERS PREFILLABLE SYRINGE PLUNGERS. The New Definition of High-Quality Components

In 2001, ISPE issued Baseline Guide Volume

Workshop on process validation

1. Certification: Employ an ASCS certified by NADCA on a full-time basis. 2. Supervisor Qualifications: Certified as an ASCS by NADCA.

Summary of Requirements for ISO 14001:2004 February 24, 2005

SCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL DRUG TRIALS

CONCEPTS OF FOOD SAFETY QUALITY MANAGEMENT SYSTEMS. Mrs. Malini Rajendran

Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Recent Updates on European Requirements and what QPs are expected to do

Transcription:

Impact Assessment in a Science & Risk Based Environment R. Legland 11/04/11

Background US GMP s EU GMP s Japan GMP s ICH Q8, Q9, Q10 Guidance ASTM Standard E2500-07 Science and Risk Based Approach to Determine Suitability for Intended Use

Regulatory Drivers GMP s US Code of Federal Regulations Title 21 Part 211 EU EudraLex (The Rules Governing Medicinal Products in the European Union), Volume 4 EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use ICH: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Q8 Pharmaceutical Development Q9 Quality Risk Management Q10 Pharmaceutical Quality System ASTM Standard E2500-2007: Guide for Specification, Design and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment

Concepts Suitability for Intended Use Manufacture of safe and effective products Science Based Approach Product and Process Understanding Definition of Critical Quality Attributes (CQA s) and Critical Process Parameters (CPP s) usually compiled in a User Requirements document and serves as the basis of the process control strategy to assure suitability Subject Matter Experts Responsible for development of strategy, CQA s, CPP s Risk Based Approach Quality Risk Management (QRM) Focus on Risk to Patient by managing and mitigating risks to product quality

Why a Science & Risk Based Approach?

Definitions System An organization of components that have a defined operational function System Boundary A limit drawn around a system to logically define what is and what is not included Impact Assessment The process of evaluating impact of the operating, controlling, alarming and failure conditions of a system

Definitions (Continued) Direct Impact A system, change or failure that has, or can have a direct effect on product quality or patient safety Indirect Impact A system, change or failure that has or can have an indirect effect on product quality or patient safety No-Impact A system, change or failure that has no effect on product quality or patient safety

Impact Assessment Flowchart Identify Systems Define System Boundaries Direct Impact Yes Impact to Quality? No Develop Supporting Rational & Criticality Indirect Impact Yes Linked to a DI System? No Impact No

Tools for Criticality Assessment Failure Modes and Effects Analysis (FMEA) Fault Tree Analysis HACCP Cause and Effect Qualitative Quantitative

Where is Impact Assessment Used? Design Review Change Control Adverse Events Deviations or discrepancies Incidents involving system, component or process failure

Designing for Impact Design PQ Commissioning Process Validation Qualification (IQ/OQ) Design Review Engineering Change Management QA Change Control Design Qualification & Impact Assessment

Change Management Impact Assessment is a key part of the Change Management process Assists with the defining the change Identifies risk to quality and patient Determines testing/verification of change to assure suitability

Adverse Events

Adverse Events Impact Assessment process should be integral in the deviation or discrepancy process to define what happened, determine the root cause and apply corrective and/or preventive action eliminate the go-forward risk

Example for Discussion # 1 Compressed Air System in a Non-Sterile OSD facility which feeds product contact processes: What are the CQA s? What are the CPP s? What is Direct Impact? Indirect? No Impact? Where would you set the system boundaries? What would the challenge strategy be?

Potential Answers for Example # 1 Compressed Air System in a Non-Sterile OSD facility which feeds product contact processes: What are the CQA s? Cleanliness of the CA only at the product contact areas, usually Viable particle, oil mist and non-viable particulate IAW ISO standards What are the CPP s? Pressure dew point What is Direct Impact? Indirect? No Impact? Direct Impact: Final filters, dew point monitoring Indirect: Primary filtration, dryers No Impact: Anything upstream of primary filtration Where would you set the system boundaries? Around direct impact components What would the challenge strategy be? Verify monitoring equipment, dryers and filtration Recurring CA testing

Example for Discussion # 2 HVAC system supplying a Non-Sterile OSD processing room (manufacturing or packaging) What are the CQA s? What are the CPP s? What s Direct Impact? Indirect? No Impact? Where would I set the system boundaries? What would the challenge strategy be?

Potential Answers for Example # 2 HVAC system supplying a Non-Sterile OSD processing room (manufacturing or packaging) What are the CQA s? Room air cleanliness Room T&RH conditions Room pressurization control What are the CPP s? HVAC filter selection and DP HVAC Leaving Air Temperature Room pressurization control What s Direct Impact? HVAC AHU and distribution ducting T&RH monitoring equipment Where would I set the system boundaries? Around AHU, excluding utilities like steam, HHW, electric, CHW, cleansteam for humidification, BAS, etc. What would the challenge strategy be? Verify direct impact equipment, commission utilities, recurring room air quality testing